Moreover, AML patients have reduced T helper 1 (Th1) cells and decreased IFN-γ secretion (21), while T helper 17 (Th17) cells are increased and secrete IL-17, promoting AML cell proliferation and inhibiting Th1 differentiation (16, 21). Here, IL17A is linked to acute myeloid leukemia.